Clinical Trials mRNA Technology Infectious Diseases Public Health Research COBRA Method COVID-19 Vaccines Clinical Research Mycobacterium tuberculosis Immunology Innovative Technologies COVID-19 Vaccine Companies DNA-based Vaccines Avian Flu Vaccines Cancer Immunotherapy Innovations in Vaccines Respiratory Syncytial Virus RSV Vaccines
The biotech company faces declining demand for its COVID-19 vaccine, a $238M manufacturing charge, and reduced 2025 revenue forecasts.